Yervoy (ipilimumab) - BMS
pemetrexed - Generic mfg.
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
carboplatin - Generic mfg.
mycophenolate mofetil - Generic mfg.
Case Report: Observational use of mycophenolate mofetil in probable steroid-unresponsive immune checkpoint inhibitor-associated transverse myelitis. (PubMed, Front Immunol) - Oct 7, 2026 - "This article reports the case of a 37-year-old male patient with biphasic pleural mesothelioma who developed ICI-associated TM after treatment with nivolumab combined with ipilimumab. Currently, the patient has restarted pemetrexed combined with carboplatin chemotherapy, and the disease status is stable. Based on recently published case series, case reports, and systematic reviews, this article discusses the second-line treatment strategies for steroid-unresponsive ICI-associated TM, aiming to provide a reference for clinical practice in managing such rare cases." 
Checkpoint inhibition • Journal • Biphasic Pleural Mesothelioma • CNS Disorders • Hematological Malignancies • Malignant Pleural Mesothelioma • Mesothelioma • Multiple Myeloma • Oncology • Pleural Mesothelioma • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42835135
 
Chunsheng Yang; Diansheng Zhong; Junping Wang; Lingping Kong; Linlin Zhang; Tao Yu; Xin Wang
 
Oct 7, 2026
 
Prev Next